Loading ...

 

ChitoCell 


Description:

ChitoCell is an oxidized regenerated cellulosic pad with broad antibacterial profile.It is indicated in surgical procedures as a hemostatic pad to stop capillary, venous, and small arterial hemorages and absorbs in the body within 7-14 days.

ChitoCell Prevents postoperative adhesion and as it absorbs blood and gets saturated, it gently swells into a gelatinous mass which aids in the formation of clot.

According to time to hemostasis (TTH) study for ChitoCell, hemostasis was achieved very fast and effectively in less than 30 s.

ChitoCell is shown to provide a strong antibacterial barrier against a broad spectrum of gram-positive, gram-negative, aerobic, anaerobic and antibiotic resistant bacteria including:  

 

Methicillin-resistant Staphylococcus aureus (MRSA)

Penicillin-resistant Streptococcus pneumoniae (PRSP)

vancomycin-resistant Enterococcus (VRE)

methicillin-resistant Staphylococcus epidermidis (MRSE)

Staphylococcus aureus

Staphylococcus epidermidis

Streptococcus pyogenes Group A

Escherichia coli

Enterococcus

Klebsiella pneumonia

Pseudomonas aeruginosa

Proteus mirabilis

 

 

Main component: Oxidized Regenerated Cellulose

 

Features & Benefits: 
    Rapid hemostasis
    Biocompatible

    Prevents postoperative adhesion
    No genotoxicity 
    No cell toxicity (ISO 10993-5)
    Complies with the requirement of ISO 10993-6 for local effect after implantation
     No irritation, no sensitivity (ISO 10993-10)
    No systemic toxicity (Acute and sub chronic toxicity)(ISO 10993-11)
    Soft and comfortable therefore suitable for all parts of body
    Sterile, absorbable and compatible with body
    Absorbable in the body
    Low pH

 

 

 

 

Indications
    All surgeries, anastomosis, tumor beds, neuro-surgeries and plastic surgeries.
    Suitable for patients with coagulopathic disorders 

    Suitable for control of capillary, venous, and small arterial hemorages

 

Contraindications

-    ChitoCell is recommended to be removed after hemostasis is achieved.

-  For avoiding interference with bone cell formation and increasing the risk of cyst formation, avoid using ChitoCell for implantation in bone defects, such as fractures.

-   Since ChitoCell will swell and could exert slight pressure, it must be removed after hemostasis in neurosurgery, bony tissues and the spinal cord surgeries

-   Do not use ChitoCell as an adhesion prevention product 

Warnings

-   ChitoCell should not be resterilized

-   ChitoCell is not intended as a substitute for careful surgery and the proper use of sutures and ligatures

-   Although ChitoCell is an antibacterial hemostatic agent, it is not intended to be used as a substitute for systemically administered therapeutic or prophylactic antimicrobial agents to control or to prevent postoperative infections

Precautions

-   Apply sufficient amount of ChitoCell on bleeding site. Although ChitoCell is a biocompatible product, to minimize the possibility of foreign body reaction, remove any excess before surgical closure.

 

Reference

Documents related to similar products such as SURGICEL ABSORBABLE HEMOSTAT (oxidized regenerated celluose)

 

Hernia Inguinal

Volvulus Surgery 

Instructions for Use:


  Clean the damaged organ by removing blood and other fluids properly. Cover the bleeding site with ChitoCell.  

 

 Address :Units 9 and 11,  Khaghani Building,No 83، Somayyeh street ,Tehran, Iran Postal code: 1571838318

Phone: +(98)21-88321517 - 19

Fax:  +(98) 21-88835224

Email: info@chitotech.com

 

 

 

 

Follow us on social media